Phase II of doxorubicin/taxol in metastatic breast cancerClaudia Pazos, Albertoi Suárez, Luis Balbiani et al.|Breast Cancer Research and Treatment|1999Cited by 10
TAXOL® (paclitaxel) 1-hour infusion plus doxorubicin as first line treatment for metastatic breast cancer (MBC) patientsE. Mickiewicz, A.M. Alvarez, Masahiro Noto et al.|European Journal of Cancer|1997Cited by 0
Paclitaxel (P) plus carboplatin (C) in advanced non-small cell lung cancer (NSCLC)Eduardo Richardet, Lydia Suarez, Federico Cóppola et al.|Lung Cancer|2000Cited by 0